JAK Inhibitors for the Treatment of Pediatric Alopecia Areata.
J Investig Dermatol Symp Proc
; 20(1): S31-S36, 2020 11.
Article
em En
| MEDLINE
| ID: mdl-33099381
ABSTRACT
Alopecia areata is a common autoimmune condition that disproportionately affects children and can significantly hinder quality of life. Few safe and effective therapies are available for the treatment of severely affected pediatric patients. JAK inhibitors have been recently established as an effective and well-tolerated therapy in adults, but there are limited data regarding the use of JAK inhibitors to treat alopecia areata in children. Here, we review the available literature regarding the use of JAK inhibitors in children in dermatology and across other medical disciplines.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Piperidinas
/
Pirimidinas
/
Alopecia em Áreas
/
Inibidores de Janus Quinases
Aspecto:
Patient_preference
Limite:
Adolescent
/
Child
/
Child, preschool
/
Humans
Idioma:
En
Revista:
J Investig Dermatol Symp Proc
Ano de publicação:
2020
Tipo de documento:
Article